Clinical practice guidelines in nephrology: Evaluation, classification, and stratification of chronic kidney disease

Pharmacotherapy

Volumn 25, Issue 4, 2005, Pages 491-502

  Bailie, George R ^a   Uhlig, Katrin ^b   Levey, Andrew S ^b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; CKD; K DOQI; Kidney Disease Outcomes Quality Initiative; National Kidney Foundation; Nephrology clinical practice guidelines

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DISEASE CLASSIFICATION; DISEASE COURSE; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION; PROTEINURIA; REVIEW; RISK FACTOR;

CHRONIC DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; PRACTICE GUIDELINES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 16344378594     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.4.491.61034     Document Type: Review

References (16)

1. Bailie GR. From dialysis outcomes quality initiative to kidney disease outcomes quality initiative: new clinical practice guidelines in nephrology - what the practicing pharmacist needs to know. Pharmacotherapy 2004;24:551-7.
2. National Kidney Foundation. K/DOQ1 clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39(suppl 1):S1-266.
3. United States Renal Data System. 2003 annual data report. Available from http://www.usrds.org/adr.htm. Accessed May 27, 2004.
4. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine in the United States: findings from the third national health and nutrition examination survey (1988-1994). Arch Intern Med 2001;161:1207-16.
5. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43(suppl 1):S1-290.
6. McClellan WM, Knight DF, Karp H, Brown WW. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am J Kidney Dis 1997;29:368-75.
7. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 1999;10:1793-800.
8. Brown WW, Peters RM, Ohmit SE, et al. The kidney early evaluation program (KEEP). AmJ Kidney Dis 2003;42:22-35.
9. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28:830-8.
10. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: third national health and nutrition examination survey. Am J Kidney Dis 1998;32:992-9. (Erratum in Am J Kidney Dis 2000;35:178).
11. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: third national health and nutrition examination survey. Am J Kidney Dis 1998;32:992-9. (Erratum in Am J Kidney Dis 2000;35:178).
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
13. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [abstr]. J Am Soc Nephrol 2000;11:A0828.
14. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999;130:461-70.
15. Mitch WE, Walser M, Buffington GA, Lemann J. A simple method of estimating progression of chronic renal failure. Lancet 1976;2:1326-8.
16. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin-dependent diabetes mellitus: prospective observational study BMJ 1997;314:783-8.